Bei Yihua, Chen Ting, Banciu Daniel Dumitru, Cretoiu Dragos, Xiao Junjie
Cardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, 333 Nan Chen Road, Shanghai, 200444, China.
Laboratory for Advanced Interdisciplinary Research, Center for Personalized Medicine/Institutes of Translational Medicine, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Adv Exp Med Biol. 2017;998:255-269. doi: 10.1007/978-981-10-4397-0_17.
Circulating exosomes could arrive in distant tissues via blood circulation, thus directly communicating with target cells and rapidly regulating intracellular signalings. Circulating exosomes and exosomal cargos are critically involved in cardiovascular pathophysiology, such as cardiomyocyte hypertrophy, apoptosis, and angiogenesis. Circulating exosomes enriched with various types of biological molecules can be changed not only in the number but also in the composite cargos upon cardiac injury, such as myocardial infarction, myocardial ischemia reperfusion injury, atherosclerosis, hypertension, and sepsis cardiomyopathy, which may further influence cardiomyocyte function and contribute to the pathogenesis of cardiovascular diseases. Thus, exosome-based therapeutic strategy may be used to attenuate myocardial injury and promote cardiac regeneration and repair. Also, more preclinical and clinical studies would be needed to investigate the potential of circulating exosomes as biomarkers for the diagnosis, risk stratification, and prognosis of cardiovascular diseases.
循环外泌体可通过血液循环抵达远处组织,从而直接与靶细胞通讯并快速调节细胞内信号传导。循环外泌体及其所载物质在心血管病理生理学过程中起着关键作用,如心肌细胞肥大、凋亡和血管生成。在诸如心肌梗死、心肌缺血再灌注损伤、动脉粥样硬化、高血压和脓毒症心肌病等心脏损伤时,富含各种生物分子的循环外泌体不仅数量会发生变化,其所载物质的组成也会改变,这可能会进一步影响心肌细胞功能并促使心血管疾病的发病。因此,基于外泌体的治疗策略可能用于减轻心肌损伤并促进心脏再生与修复。此外,还需要更多的临床前和临床研究来探究循环外泌体作为心血管疾病诊断、风险分层和预后生物标志物的潜力。